Defining and targeting residual virus on combined antiretroviral therapy

Ward, Christopher 2014. Defining and targeting residual virus on combined antiretroviral therapy. Future Virology 9 (9) , pp. 791-793. 10.2217/fvl.14.72

Full text not available from this repository.

Abstract

Therapeutic targeting of residual HIV following successful antiretroviral suppression represents a potential mechanism of HIV cure. This meeting report describes the findings of two eminent investigators speaking at a session of the 20th International Conference of the International AIDS Society. This conference attracted approximately 14,000 delegates comprising patients, scientists, clinicians and other key stakeholders. Herein, two putative targets of novel therapy are described: the kick and kill approach offered by HDAC inhibitors and the use of bispecific antibodies to direct CD8 T-cell killing in germinal centers.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	Q Science > QR Microbiology > QR355 Virology
Publisher:	Future Medicine
ISSN:	1746-0794
Last Modified:	11 Dec 2020 03:17
URI:	https://orca.cardiff.ac.uk/id/eprint/78668

Actions (repository staff only)

Edit Item